Cetera Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-6,801
Closed -$669K 973
2019
Q3
$669K Sell
6,801
-144
-2% -$13.7K 0.03% 461
2019
Q2
$634K Buy
6,945
+63
+0.9% +$5.98K 0.03% 490
2019
Q1
$642K Sell
6,882
-55
-0.8% -$4.81K 0.03% 429
2018
Q4
$443K Sell
6,937
-3,601
-34% -$266K 0.03% 509
2018
Q3
$941K Buy
10,538
+4,807
+84% +$425K 0.05% 374
2018
Q2
$454K Buy
5,731
+410
+8% +$34K 0.03% 529
2018
Q1
$472K Sell
5,321
-8,424
-61% -$809K 0.03% 485
2017
Q4
$1.43M Sell
13,745
-9,781
-42% -$1.1M 0.09% 230
2017
Q3
$3.42M Sell
23,526
-1,329
-5% -$181K 0.21% 117
2017
Q2
$3.23M Buy
24,855
+150
+0.6% +$18.4K 0.2% 119
2017
Q1
$3.08M Buy
24,705
+492
+2% +$58.9K 0.21% 112
2016
Q4
$2.8M Buy
24,213
+127
+0.5% +$14.1K 0.21% 115
2016
Q3
$2.52M Buy
24,086
+469
+2% +$50.8K 0.19% 121
2016
Q2
$2.32M Sell
23,617
-96
-0.4% -$9.93K 0.18% 132
2016
Q1
$2.37M Buy
23,713
+223
+0.9% +$23K 0.2% 125
2015
Q4
$2.82M Buy
23,490
+21,444
+1,048% +$2.48M 0.24% 103
2015
Q3
$219K Sell
2,046
-103
-5% -$12.8K 0.02% 581
2015
Q2
$249K Sell
2,149
-57
-3% -$6.52K 0.02% 585
2015
Q1
$255K Sell
2,206
-21,156
-91% -$2.53M 0.02% 551
2014
Q4
$2.62M Sell
23,362
-929
-4% -$98K 0.25% 104
2014
Q3
$2.3M Sell
24,291
-15
-0.1% -$1.35K 0.18% 106
2014
Q2
$2.08M Sell
24,306
-690
-3% -$52.5K 0.23% 109
2014
Q1
$1.75M Buy
24,996
+500
+2% +$39.6K 0.24% 95
2013
Q4
$2.07M Sell
24,496
-2,228
-8% -$176K 0.31% 81
2013
Q3
$2.06M Buy
26,724
+16,394
+159% +$1.15M 0.37% 62
2013
Q2
$604K Buy
+10,330
New +$622K 0.13% 193

Other funds holding CELG

Cetera Advisors's CELG Position: Q4 2019 in Review

Cetera Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,801 shares — an estimated $669K sold.

Cetera Advisors first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $3.42M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Cetera Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Cetera Advisors sold 6,801 Celgene Corp shares in Q4 2019, an estimated $669K.
  • Cetera Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Cetera Advisors's Celgene Corp position peaked at $3.42M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Cetera Advisors's 13F filing for Q4 2019, filed 10 Feb 2020.